lacosamide
NDC 69539-028, lacosamide, tablet, film coated, from MSN LABORATORIES PRIVATE LIMITED.
- Product NDC
- 69539-028
- Status
- Listed
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204921
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/69539-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69539-028-05 | 69539002805 | 500 TABLET, FILM COATED in 1 BOTTLE (69539-028-05) |
| 69539-028-60 | 69539002860 | 60 TABLET, FILM COATED in 1 BOTTLE (69539-028-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0ae4e2d1-305d-4045-95da-cfe7c2d8b435
Use it
Look up 69539-028 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69539-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69539-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.